RGS
Regis Corporation
RGS trails on the overall score without a compensating advantage in the available component scores.
TSLA
Tesla, Inc.
TSLA has the edge over RGS overall, supported by lower modeled downside and stronger modeled upside.
RGS Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Stable | |
| Under pressure |
RGS's profitability and cash flow are currently stable, but its revenue and balance sheet are under pressure.
TSLA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Strong |
TSLA's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
RGS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 0.5x | $1.05 | -96% |
| Fair | 0.6x | $1.27 | -95% |
| Expensive | 0.7x | $1.39 | -94% |
| Current | 11x | $23.55 | — |
Historical ranges are pointers, not guarantees.
RGS's PE is in its expensive range at 11x.
TSLA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 60x | $54.70 | -86% |
| Fair | 174x | $158 | -60% |
| Forward | 196x | $397 | — |
| Expensive | 415x | $378 | -4.9% |
| Current | 437x | $397 | — |
Historical ranges are pointers, not guarantees.
TSLA has the edge over RGS in the historical PE scenario, which offers more potential upside but is not a forecast.
RGS Forward outlook
There aren't enough analyst estimates for RGS to show an outlook.
TSLA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for TSLA, with profitability holding steady. However, they disagree widely on these estimates.
RGS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $2.10 | -96% |
| Q2 2026 | $2.41 | -95% |
| Q1 2026 | $44.58 | +9.4% |
| Q4 2025 | $44.40 | +12% |
| Q3 2025 | $46.95 | +26% |
| Q2 2025 | $46.10 | +20% |
| Q1 2025 | $40.74 | +$42.71 |
| Q4 2024 | $39.66 | +$41.43 |
RGS has the edge over TSLA on earnings, with more consistent year-over-year improvement.
TSLA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.03 | +123% |
| Q3 2026 | $0.91 | -39% |
| Q2 2026 | $1.08 | -38% |
| Q1 2026 | $1.09 | -40% |
| Q4 2025 | $1.08 | -47% |
| Q3 2025 | $1.50 | -59% |
| Q2 2025 | $1.73 | -51% |
| Q1 2025 | $1.82 | -53% |
| Q4 2024 | $2.04 | -53% |
TSLA's earnings per share have fallen from their peak: $0.91 over the past year, against $4.30 in late 2023.
RGS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.3M | -7.8% |
| Q2 2026 | $56M | -7.3% |
| Q1 2026 | $52.4M | -8% |
| Q4 2025 | $57.1M | +22% |
| Q3 2025 | $59M | +28% |
| Q2 2025 | $60.4M | +22% |
| Q1 2025 | $57M | +16% |
| Q4 2024 | $46.7M | -8.5% |
RGS has the edge over TSLA on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 9.8% | -0.3 points |
| Q2 2026 | 12% | -0.3 points |
| Q1 2026 | 11% | +2.1 points |
| Q4 2025 | 11% | -0.9 points |
| Q3 2025 | 10% | +5.4 points |
| Q2 2025 | 12% | +2.8 points |
| Q1 2025 | 8.8% | +0.5 points |
| Q4 2024 | 12% | +2.4 points |
RGS has the edge over TSLA on profitability, with a higher operating margin.
TSLA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $28B | -0.2% |
| Q2 2026 | $28.2B | +26% |
| Q1 2026 | $22.4B | +16% |
| Q4 2025 | $24.9B | -3.1% |
| Q3 2025 | $28.1B | +12% |
| Q2 2025 | $22.5B | -12% |
| Q1 2025 | $19.3B | -9.2% |
| Q4 2024 | $25.7B | +2.1% |
TSLA's revenue has picked up after two years of holding roughly level: $28B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.6% | -3.2 points |
| Q2 2026 | 1.4% | -2.7 points |
| Q1 2026 | 4.2% | +2.1 points |
| Q4 2025 | 5.7% | -0.5 points |
| Q3 2025 | 5.8% | -5 points |
| Q2 2025 | 4.1% | -2.2 points |
| Q1 2025 | 2.1% | -3.4 points |
| Q4 2024 | 6.2% | -2 points |
TSLA's operating margin was 2.6% last quarter, down 3.2 points from the same quarter a year ago, near the bottom of its range since 2019.
RGS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.1M | +11% |
| Q2 2026 | $3.6M | -42% |
| Q1 2026 | $4.8M | -19% |
| Q4 2025 | $891K | -48% |
| Q3 2025 | $1.9M | +$3.2M |
| Q2 2025 | $6.2M | +23% |
| Q1 2025 | $5.9M | +$6.2M |
| Q4 2024 | $1.7M | +$5.9M |
RGS has the edge over TSLA on cash flow, with more consistent year-over-year improvement.
TSLA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.5B | -62% |
| Q2 2026 | -$1.1B | -848% |
| Q1 2026 | $1.4B | +117% |
| Q4 2025 | $1.4B | -30% |
| Q3 2025 | $4B | +46% |
| Q2 2025 | $146M | -89% |
| Q1 2025 | $664M | +$3.2B |
| Q4 2024 | $2B | -1.6% |
TSLA still generates free cash flow, though less than at its 2025 peak: $3.3B over the past year.
RGS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.5% | +44K shares |
| 1 year | +5.1% | +142K shares |
| 3 years | +24% | +561K shares |
| 5 years | +59% | +1.1M shares |
| Available history | +63% | +1.1M shares |
RGS has 3M diluted shares, up 5.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | $1,000 |
TSLA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1M shares |
| 1 year | +0.4% | +15M shares |
| 3 years | +1.4% | +48M shares |
| 5 years | +5.1% | +172M shares |
| Available history | +33% | +886M shares |
TSLA has the edge over RGS on shareholder dilution, with a more favorable share count trend.
RGS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.2x | Elevated |
| Q2 2026 | 3.2x | Elevated |
| Q1 2026 | 3.2x | Elevated |
| Q4 2025 | 3.4x | Elevated |
| Q3 2025 | 3.5x | Elevated |
| Q2 2025 | 4.1x | High |
| Q1 2025 | 4.8x | High |
| Q4 2024 | 5.2x | High |
RGS's net debt is about 3.2 years of its operating earnings (EBITDA), down from 3.5 years a year ago.
TSLA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -1.1x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
TSLA has the edge over RGS on leverage, with a lower net debt burden relative to earnings.
RGS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.3 | Neutral |
| Stochastic | 35.1 | Neutral |
RGS's weekly RSI is 36 (neutral) and its Stochastic is 35 (neutral).
TSLA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.3 | Neutral |
| Stochastic | 72.6 | Neutral |
TSLA's weekly RSI is 54 (neutral) and its Stochastic is 73 (neutral).
RGS PE vs Consumer Cyclical Sector
| Metric | RGS | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 18x | 38% below |
| PE % | 92 | 47 | 45 pts above |
RGS has the edge over TSLA on valuation relative to its sector.
TSLA PE vs Consumer Cyclical Sector
| Metric | TSLA | Sector median | Relative |
|---|---|---|---|
| PE | 437x | 18x | 2,324% above |
| PE % | 84 | 47 | 37 pts above |
TSLA is trading at 437x earnings, a 2324% premium to the Consumer Cyclical sector's median of 18x.
RGS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.8 | 15% below |
| 20 week MA | $27.7 | 15% below |
| 50 week MA | $26.5 | 11% below |
| 100 week MA | $24.8 | 5% below |
| 200 week MA | $21.2 | 11% above |
RGS has fallen below most of its moving averages, though it's still 11% above its 200-week average.
TSLA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $376.0 | 5.7% above |
| 20 week MA | $364.0 | 9.2% above |
| 50 week MA | $393.6 | 1% above |
| 100 week MA | $372.1 | 6.8% above |
| 200 week MA | $296.9 | 34% above |
TSLA has the edge over RGS on trend strength, trading above more of its moving averages.
RGS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $359.0 | $189.6 | -47% |
| 2021 | $189.6 | $33.8 | -82% |
| 2022 | $33.8 | $24.2 | -28% |
| 2023 | $24.2 | $9.45 | -61% |
| 2024 | $9.45 | $25.5 | +170% |
| 2025 | $25.5 | $27.4 | +7.4% |
| 2026 YTD | $27.4 | $23.6 | -14% |
RGS has the edge over TSLA on returns for 2026, with the stronger performance.
TSLA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.7 | $220.6 | +669% |
| 2021 | $220.6 | $355.7 | +61% |
| 2022 | $355.7 | $123.2 | -65% |
| 2023 | $123.2 | $248.5 | +102% |
| 2024 | $248.5 | $431.7 | +74% |
| 2025 | $431.7 | $475.2 | +10% |
| 2026 YTD | $475.2 | $397.5 | -16% |
TSLA's yearly returns have swung widely, from +669% in 2020 to −65% in 2022. It's down 16% so far in 2026.